Abstract
Human milk oligosaccharides (HMO) contribute to innate immunity by enhancing growth of beneficial bacteria, epithelial cell maturation and mucosal barrier integrity. They have immunomodulatory effects and can block pathogen binding to host cell surface glycans or receptors. We investigated the effects of 2’-fucosyllactose (2’FL), 6’-sialyllactose (6’SL), 3’-sialyllactose (3’SL) and lacto-N-neoTetraose (LNnT) on human respiratory epithelial cell lines or peripheral blood mononuclear cells (PBMCs) following respiratory viral infectionin vitro. Expression of cytokines and viral load were monitored in infected cells. These biomarkers of innate immunity were selected since viral load and cytokine levels (IP-10, MIP-1α, IL-6, IL-8, TNF-α) have been correlated with disease severity in respiratory syncytial virus (RSV) and influenza (IAV) virus infectionin vivo. 2’FL significantly decreased RSV viral load and cytokines associated with disease severity (IL-6, IL-8, MIP-1α) and inflammation (TNF-α, MCP-1) in airway epithelial cells. LNnT and 6’SL significantly decreased IAV viral load in airway epithelial cells. 6’SL dose-dependently down-regulated IP-10 and TNF-α in RSV infected PBMCs. HMO at or below levels found in breast milk enhance innate immunity to respiratory viruses in vitro and may interact directly with cells to modulate biomarkers of innate immunity.
Highlights
Human milk oligosaccharides (HMO) contribute to innate immunity through several potential paths
The ability of HMO treatment to reduce cytokines associated with respiratory viral inflammation was evaluated. 6’SL dose-dependently decreased IL-6 in Influenza A Virus (IAV) infected Calu-3 cells (Figure 4(C))
Adult peripheral blood mononuclear cells (PBMCs) were used to investigate the effects of HMO and monosaccharides on PBMC response to respiratory syncytial virus (RSV) challenge
Summary
Human milk oligosaccharides (HMO) contribute to innate immunity through several potential paths. (2014) Human Milk Oligosaccharides Enhance Innate Immunity to Respiratory Syncytial Virus and Influenza in Vitro. Port initial development of infant gut microbiota by cultivating colonization with beneficial bacteria. HMO enhance growth [1] [2] and adhesion [3] of probiotic bacteria to gut epithelial cells. Bifidobacteria grown in the presence of HMO stimulate increased expression of tight junction proteins in gut epithelial cells [3] in vitro, suggesting HMO indirectly promote gut barrier integrity. 2’FL and LNnT were shown to promote gut epithelial cell maturation and barrier function in vitro, suggesting specific HMO directly promote epithelial cell maturation in the small intestine [4]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
